Effect ofFeitai capsule combined with mycobacterium vaccae on immune function in elderly patients with pulmonary tuberculosis

VernacularTitle:肺泰胶囊联合母牛分枝杆菌对老年肺结核患者免疫功能的影响
Author: Lan WEI ; Yuzhuo LI ; Xuebo QIN ; Xiaoliang DUAN ; Haijun PENG ; Junpeng FENG ; Hui LI
Publication Type:Journal Article
Keywords: Tuberculosis,pulmonary; Antitubercular agents; Mycobacterium; Tuberculosis vaccines; Feitai capsule
From: International Journal of Traditional Chinese Medicine 2015;(4):303-306
CountryChina
Language:Chinese
Abstract: t=2.331,P=0.022) T cell levels and CD4+/CD8+ ratio (1.1 ± 0.2vs. 0.9 ± 0.2;t=4.488,P<0.001) showed significant difference between post-treatment and pretreatment. CD3+, CD4+, CD8+ T cell levels and CD4+/CD8+ ratio after treatment showed significant different between the two groups (t values were 3.920, 11.966, 5.573, 10.700,P<0.01). After the treatment, the cure rate in treatment group was significantly higher than that in the control group (80%vs. 56%;χ2=5.561,P=0.018). The rates of sputum conversion from positive to negative (72.0%vs. 50.0%;χ2=5.086,P=0.024)and cavity closure (36.0%vs. 16.0%;χ2=5.198,P=0.023) 6 months after treatment in the treatment group were higher than those in the control group.ConclusionFeitai capsule combined with mycobacterium vaccae can significantly improve the immune function in elderly patients with pulmonary tuberculosis.